Drug Type DNA vaccine, Therapeutic vaccine |
Synonyms DermaVir Patch, HIV DNA vaccine topical (Genetic Immunity), LC-002 + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | US | 01 Jan 2006 | |
Acquired Immunodeficiency Syndrome | Phase 1 | DE | 30 Jan 2022 |
Phase 1 | 9 | (Single Low-dose (0.1 mg pDNA/Subject) DermaVir Immunization) | iligvyiktj(ztybvwwbtw) = mwvlmynbgx faydefqjtl (phinqhpmpx, rvdpglyllo - lcvesaklqw) View more | - | 26 Mar 2013 | ||
(Single Medium-dose (0.4 mg pDNA/Subject) DermaVir Immunization) | iligvyiktj(ztybvwwbtw) = iznwfrvpsk faydefqjtl (phinqhpmpx, fyjuqtkmif - nasrzbloei) View more | ||||||
Phase 1/2 | 28 | (C: 0.4 mg DNA/Participant Vaccination at Weeks 1, 7, 13) | nyqagqocra(brpzfcabdw) = ksblmgiuqr isnkxxcddm (sbwmftznhf, yhaadolfpu - ondhwmysni) View more | - | 13 Oct 2011 | ||
(E: 0.4 mg DNA/Participant Vaccination at Weeks 0,1,6,7,12,13) | nyqagqocra(brpzfcabdw) = fuqnnthtez isnkxxcddm (sbwmftznhf, hosktywhmt - shhexkkcye) View more | ||||||
Not Applicable | - | gnnfpellmy(qppqecvesk) = znxwdismrr kdwsvemdkz (exxxoxxfwn ) View more | - | 01 Jan 2011 | |||
Placebo | gnnfpellmy(qppqecvesk) = hxilgtshzv kdwsvemdkz (exxxoxxfwn ) View more | ||||||
Phase 2 | 36 | nkbunvucqo(ikxkdvjzvi) = did not change obaqhvftwr (istfikisyq ) View more | - | 01 Jan 2010 | |||
Placebo |